Literature DB >> 10970923

Cost-utility analysis in depression: the McSad utility measure for depression health states.

K J Bennett1, G W Torrance, M H Boyle, R Guscott.   

Abstract

Cost-utility analysis, used increasingly over the past decade to analyze costs and effects in treating physical diseases, has received little attention in psychiatry. This article briefly introduces the concepts and methods of utility measurement and illustrates it using depression as an example. The authors describe the McSad health state classification system for depression, a direct utility measure for depression, and report results of an application of McSad among 105 patients who had a recent history of depression. Utility measures express patient preferences for specific health states on a scale ranging from 0, representing death, to 1, representing perfect health. These scores provide the weights used to calculate the number of quality-adjusted life-years gained by an intervention or service. McSad allows a patient's depression health state to be classified according to level of functioning in six dimensions of depression and to be compared with other hypothetical depression health states in order to produce utility scores indicating the patient's relative preferences.

Entities:  

Mesh:

Year:  2000        PMID: 10970923     DOI: 10.1176/appi.ps.51.9.1171

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  15 in total

Review 1.  Benefits and burdens of placebos in psychiatric research.

Authors:  Scott Y H Kim
Journal:  Psychopharmacology (Berl)       Date:  2003-04-09       Impact factor: 4.530

Review 2.  The role of marketing in pharmaceutical research and development.

Authors:  John E Calfee
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

3.  Valuation of depression co-occurring with a somatic condition: feasibility of the time trade-off task.

Authors:  Katerina Papageorgiou; Karin M Vermeulen; Fenna R M Leijten; Erik Buskens; Adelita V Ranchor; Maya J Schroevers
Journal:  Health Expect       Date:  2014-11-13       Impact factor: 3.377

4.  The stability of utility scores: test-retest reliability and the interpretation of utility scores in elective total hip arthroplasty.

Authors:  D Feeny; C M Blanchard; J L Mahon; R Bourne; C Rorabeck; L Stitt; S Webster-Bogaert
Journal:  Qual Life Res       Date:  2004-02       Impact factor: 4.147

5.  Using the effect size to model change in preference values from descriptive health status.

Authors:  Kristy Sanderson; Gavin Andrews; Justine Corry; Helen Lapsley
Journal:  Qual Life Res       Date:  2004-09       Impact factor: 4.147

6.  Predictors of health-related quality-of-life utilities among persons with posttraumatic stress disorder.

Authors:  Jason N Doctor; Lori A Zoellner; Norah C Feeny
Journal:  Psychiatr Serv       Date:  2011-03       Impact factor: 3.084

Review 7.  The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research.

Authors:  Patrick E McKnight; Todd B Kashdan
Journal:  Clin Psychol Rev       Date:  2009-02-07

Review 8.  A decision analysis of long-term lithium treatment and the risk of renal failure.

Authors:  U Werneke; M Ott; E Salander Renberg; D Taylor; B Stegmayr
Journal:  Acta Psychiatr Scand       Date:  2012-03-09       Impact factor: 6.392

9.  Cost-effectiveness of electroconvulsive therapy compared to repetitive transcranial magnetic stimulation for treatment-resistant severe depression: a decision model.

Authors:  L Vallejo-Torres; I Castilla; N González; R Hunter; P Serrano-Pérez; L Perestelo-Pérez
Journal:  Psychol Med       Date:  2014-10-30       Impact factor: 7.723

10.  Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder.

Authors:  Christophe Sapin; Bruno Fantino; Marie-Laure Nowicki; Paul Kind
Journal:  Health Qual Life Outcomes       Date:  2004-05-05       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.